A step further in improving clinical trials: an electronic informed consent fully integrated into the eCOA solution
A new capability on one single device for your clinical trials
This new capability is proposed on one single device, making it simpler for the patients, more convenient for the sites, and cost-efficient for the sponsors.
Kayentis has put in place for its eCOA solutions a world-class connectivity capacity, which will benefit to SecureConsent solution.
Should they use it for one or the other service, the sites will also benefit from a 24/7 specifically dedicated helpdesk contact.
More compliance and understanding for the patients with the electronic informed consent form
This is a new step for clinical trials, taking compliance and patient understanding further: information to the patient made easier and clearer will drive compliance enhancements, and no doubt, contribute to higher patient engagement.
Guillaume JUGE, CEO – Kayentis
// Read more about the benefits of the electronic informed consent form (eICF) //
Last update : 23 May 2016